Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD to phase out COVID-19 medicines facilitations
The relaxation will last until 31 August 2020 and then cease.
Temporary retail supply measures to cease on 31 August. 

Temporary measures to allow vets to delegate the supply of veterinary medicines to internet retailers or wholesale dealers for home delivery are to cease on the 31 August.

The Veterinary Medicines Directorate (VMD) first relaxed the enforcement of the Veterinary Medicines Regulations (VMF) in April to meet social distancing guidelines. Now, in light of the easing of lockdown, the VMD has announced a final extension to these measures.

In a statement, the VMD writes: ‘In view of the updated Government guidelines in response to the COVID-19 pandemic, this notice amended has been amended to provide that the VMD has made a final extension to the temporary relaxation of the specific provisions of the Veterinary Medicines Regulations 2013. This relaxation will now last until 31 August 2020 and then cease’.

The VMD states that it will not issue an improvement notice if there are breaches of the relevant provisions of Schedule 3 of the VMR during this period.
 
 'This is a temporary VMD enforcement policy in relation to specific obligations under the VMR only,' the VMD writes. 'The VMR continue to apply. The VMD may continue to take action to enforce those obligations in cases where the procedures described in the statement are not followed.'

‘These changes do not affect the existing provisions that allow a veterinary surgeon in exceptional circumstances, for example for animal welfare reasons, to instruct a Wholesale Dealer Authorisation holder to deliver medicines to the client’s premises.’

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.